Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("KENDE M")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 49

  • Page / 2

Export

Selection :

  • and

THE MODE OF SECRETION OF ALPHA -AMYLASE IN BARLEY ALEURONE LAYERSLOCY R; KENDE M.1978; PLANTA; DEU; DA. 1978; VOL. 143; NO 1; PP. 89-99; BIBL. 28 REF.Article

B.K. VIRUS HOEMAGGLUTININKENDE M; UJ M; SZUECS G et al.1979; ACTA MICROBIOL. ACAD. SCI. HUNGAR; HUN; DA. 1979; VOL. 26; NO 3; PP. 179-184; BIBL. 16 REF.Article

HAEMAGGLUTINATION-INHIBITING ANTIBODIES TO B.K. VIRUS IN HUNGARYSZUECS G; KENDE M; UEJ M et al.1979; ACTA MICROBIOL. ACAD. SCI. HUNGAR; HUN; DA. 1979; VOL. 26; NO 3; PP. 173-178; BIBL. 20 REF.Article

THERAPY OF AKR LEUKEMIA WITH ANTIBODY-DEPENDENT NORMAL LYMPHOCYTES AND CYCLOPHOSPHAMIDE.PUTMAN DL; KIND PD; KENDE M et al.1977; CANCER IMMUNOL. IMMUNOTHERAPY; GERM.; DA. 1977; VOL. 3; NO 2; PP. 97-99; BIBL. 16 REF.Article

Strategic standardization in trade with network externalities = Standardisation stratégique commerciale dans un réseau externeKENDE, M.1991, 37 p.Book

ADOPTIVE IMMUNOCHEMOTHERAPY OF A TRANSPLANTALLE AKR LEUKEMIA (K36).PUTMAN DL; KIND PD; GOLDIN A et al.1978; INTERNATION. J. CANCER; SWITZ.; DA. 1978; VOL. 21; NO 2; PP. 230-233; ABS. FR.; BIBL. 25 REF.Article

STUDIES OF THE EFFECTS OF BACILLUS CALMETTE-GUERIN ON MOLONEY SARCOMA VIRUS-INDUCED TUMORS IN NORMAL AND IMMUNOSUPPRESSED = ETUDES SUR LES EFFETS DU BCG SUR LES TUMEURS INDUITES PAR LE VIRUS DU SARCOME DE MOLONEY CHEZ DES SOURIS NORMALES ET SOUMISES A UNE IMMUNODEPRESSIONHOUCHENS DP; GOLDBERG AI; GASTON MR et al.1973; CANCER RES.; U.S.A.; DA. 1973; VOL. 33; NO 4; PP. 685-690; BIBL. 21REF.Serial Issue

RELATIONSHIP BETWEEN WHITE BLOOD CELL COUNT AND DIAGNOSIS AND THERAPEUTIC RESPONSE IN AKR MICE WITH SPONTANEOUS LEUKEMIA (LYMPHOMA) = RELATION ENTRE LE NOMBRE DE GLOBULES BLANCS ET LE DIAGNOSTIC ET LA REPONSE THERAPEUTIQUE CHEZ DES SOURIS AKR ATTEINTES DE LEUCEMIE SPONTANEE (LYMPHOME)KENDE M; GOLDBERG AI; GLYNN JP et al.1972; CANCER CHEMOTHERAPY REP., 1,; U.S.A.; DA. 1972; VOL. 56; NO 6; PP. 683-690; BIBL. 8REF.Serial Issue

A TWO-STAGE THERAPEUTIC DESIGN IN THE SPONTANEOUS AKR LYMPHOMA SYSTEM = UN SCHEMA THERAPEUTIQUE EN 2 TEMPS DU SYSTEME DU LYMPHOME AKR SPONTANEGOLDBERG AI; GLYNN JP; KENDE M et al.1972; CANCER RES.; U.S.A.; DA. 1972; VOL. 32; NO 6; PP. 1321-1328; BIBL. 16REF.Serial Issue

Licensing, software synergy, and indirect network externalities = Autorisation de licence, synergie de logiciel et externalités indirectes de réseauKENDE, M.1995, 18 p.Book

Profitability under an open versus a closed system = Profitabilité dans un système ouvert ou à l'inverse ferméKENDE, M.1992, 30 p.Book

IMMUNOPREVENTION OF X-RAY-INDUCED LEUKEMIAS IN THE C57BL MOUSE.PETERS RL; SASS B; STEPHENSON JR et al.1977; PROC. NATION. ACAD. SCI. U.S.A.; U.S.A.; DA. 1977; VOL. 74; NO 4; PP. 1697-1701; BIBL. 24 REF.Article

Monopoly incentives to license a product with network externalities = Les incitations pour un monopole à accorder une licence de produit avec externalités de réseauKENDE, M.1992, 20 p.Book

Government support of the European information technology industry = Aide publique à l'industrie européenne des technologies de l'informationKENDE, M.1996, 36 p.Book

Gains from standardization: the case of numerical controls = Les bénéfices issus de la standardisation: le cas des contrôles numériquesKENDE, M.1991, 57 p.Book

NATURALLY OCCURRING HUMORAL IMMUNITY TO ENDOGENOUS XENOTROPIC AND AMPHOTROPIC TYPE-C VIRUS IN THE MOUSEKENDE M; VERONESE F; HILL DW et al.1981; INT. J. CANCER; ISSN 0020-7136; CHE; DA. 1981; VOL. 27; NO 2; PP. 235-242; BIBL. 2 P.Article

TYPE-C VIRUS STRUCTURAL ANTIGENS ON THE SURFACE OF THE INFECTED CELL AS DETERMINED BY A HUMORAL CYTOTOXICITY ASSAY.KENDE M; SASS B; HINO S et al.1978; INTERNATION. J. CANCER; SWITZ.; DA. 1978; VOL. 21; NO 2; PP. 194-203; ABS. FR.; BIBL. 31 REF.Article

Licensing and the battle between standards = L'autorisation de licence et la bataille entre les standardsKENDE, M.1995, 24 p.Book

A note on backward compatibility = Note sur la compatibilité rétroactiveKENDE, M.1993, 11 p.Book

NATURALLY OCCURRING LYMPHOCYTE MEDIATED IMMUNITY TO ENDOGENOUS TYPE-C VIRUS IN THE MOUSE. BLOCKING OF THE LYMPHOCYTE REACTIVITY WITH ANTISERA TO THE VIRUSKENDE M; HILL R; DINOWITZ M et al.1979; J. EXPER. MED.; USA; DA. 1979; VOL. 149; NO 2; PP. 358-371; BIBL. 47 REF.Article

DRUG-MEDIATED IMMUNOGENIC CHANGES OF VIRUS-INDUCED LEUKEMIA IN VIVOHOUCHENS DP; BONMASSAR E; GASTON MR et al.1976; CANCER RES.; U.S.A.; DA. 1976; VOL. 36; NO 4; PP. 1347-1352; BIBL. 17 REF.Article

IMMUNOCHEMOTHERAPY OF TRANSPLANTABLE MOLONEY LEUKEMIA WITH CYCLOPHOSPHAMIDE AND ALLOGENEIC SPLEEN LYMPHOCYTES AND REVERSAL OF GRAFT VERSUS-HOST DISEASE WITH ALLOANTISERUM = IMMUNOCHIMIOTHERAPIE DE LA LEUCEMIE DE MOLONEY TRANSPLANTABLE AVEC LE CYCLOPHOSPHAMIDE ET DES LYMPHOCYTES SPLENIQUES ALLOGENIQUES ET ANTAGONISME DE LA MALADIE DE LA GREFFE CONTRE L'HOTE AVEC L'ALLOANTISERUMKENDE M; KEYS LD; GASTON M et al.1975; CANCER RES.; U.S.A.; DA. 1975; VOL. 35; NO 2; PP. 346-351; BIBL. 21REF.Article

IMMUNOPREVENTION OF NATURALLY OCCURRING ENDOGENOUS MURINE TYPE-C RNA VIRUSES.KENDE M; STEPHENSON JR; KELLOFF GJ et al.1978; NATURE; G.B.; DA. 1978; VOL. 273; NO 5661; PP. 383-385; BIBL. 30 REF.Article

Carrier-mediated delivery of antiviral agentsCANONICO, P. G; KENDE, M; GABRIELSEN, B et al.Advances in virus research. 1988, Vol 35, pp 271-312, issn 0065-3527Article

Shift in genomic molecular patterns of human rotaviruses over an eighteen-month period in HungarySZÜCS, G; KENDE, M; UJ, M et al.Intervirology. 1987, Vol 28, Num 2, pp 110-113, issn 0300-5526Article

  • Page / 2